Since the earliest days of mobile phones, a small but steady contingent of environmental activists, conspiracy-inclined folks and some scientists have warned about the hidden damage they could be causing to our bodies, due to the radio frequency energy mobile phones use to communicate with cell towers. They fear that this non-ionizing radiation could penetrate our cells and cause damage, increasing our risk of brain and head cancer.
Tagged With cancer
In the US, so far 29 states and DC have legalised medical marijuana, as modern research has suggested that weed can help treat conditions like chronic pain and the side effects of chemotherapy. Some companies, though, are abusing the growing acceptance of weed for medicinal purposes. On Wednesday, the FDA reported that it has sent warning letters to four companies claiming that marijuana-based products can treat or cure cancer.
Every generation has had its breakthrough that promised to, at long last, finally cure cancer, but this time around the chances of actually pulling it off are looking pretty good. Rapid advancement in fields like genetics have led to incredible success using immunotherapies to turn patients' own bodies into cancer-fighting machines. Pharmaceutical companies, philanthropic billionaires and the US government's cancer moonshot program are all racing to develop new treatments, with a handful already approved.
Despite what alternative medicine and natural health advocates would have you believe, taking apricot kernel extract as a cancer treatment is a very, very bad idea.
This reminder comes off the back of the case of a 67 year old Victorian man, who legit developed cyanide poisoning from ingesting apricot kernel extract.
On Wednesday, the US Food and Drug Administration approved a treatment that genetically modifies a patient's own blood cells in order to attack childhood leukaemia, a landmark decision opens the door for an era of FDA-sanctioned human gene modification.
You have, as of today, a one hundred per cent chance of dying. But a lot of people would like a little more time to do things, like eat interestingly-shaped pastas, or play catch with their grandchildren. That makes sense. I'd also like to do those things. But sometimes, our pursuit to eat lots of pasta or die trying leads some of us to make decisions that don't actually help -- like taking alternative, instead of conventional, cancer treatments.
This week marked a major milestone in medicine: On Wednesday, a US Food and Drug Administration panel unanimously recommended the approval of the first CAR-T therapy, a pioneering new cancer drug from Novartis that genetically engineers a patient's own white blood cells to recognise and attack the cancer cells invading their body.
Practically everyone who likes space and has lots of money is trying to get to Mars in the near future. But before anyone reaches the Red Planet, there are plenty of concerns to mull over, most notably that our bodies were not built to live in a barren litter box with a thin atmosphere. But the journey to Mars is an equal concern. An unnerving new study suggests that the trip to Mars could put passengers at a higher risk to develop cancer -- possibly two times greater than what experts previously thought.
There's no limit to viral ruthlessness. These lifeless packets of genetic code cause countless ails, often without a known cure. One such monster spends most of its time as a seemingly benign strand of DNA that could sit latent for years before striking, causing cells to turn into a rare but aggressive form of skin cancer called Merkel cell carcinoma.
In a study that's bound to attract considerable controversy, a pair of researchers are claiming that between 60 and 66 per cent of all cancer-causing mutations are the result of random DNA copying errors, making them essentially unavoidable. The new research is offering important insights into how cancer emerges, and how it should be diagnosed and treated -- but many questions remain.
Following the deaths of five patients, Juno Therapeutics has decided to pull the plug on an experimental cancer treatment that boosts the power of a patient's immune cells. The news comes just days after the company's rival, Kite Pharma, announced its success with a similar method, showing there's still hope for this potentially revolutionary gene therapy.